A proinflammatory cytokine inhibits p53 tumor suppressor activity

Journal of Experimental Medicine

Volumn 190, Issue 10, 1999, Pages 1375-1382

  Hudson, James D ^a   Shoaibi, Mahmood A ^a   Maestro, Roberta ^b   Carnero, Amancio ^a   Hannon, Gregory J ^c   Beach, David H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

Apoptosis; Growth arrest; Inflammation and cancer; Macrophage migration inhibitory factor; p53

Indexed keywords

CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; GENETIC STABILITY; GROWTH DISORDER; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSACTIVATION;

ANIMALS; APOPTOSIS; CELL LINE; CHRONIC DISEASE; FIBROBLASTS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; NEOPLASMS; NITRIC OXIDE; RATS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033571182     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.10.1375     Document Type: Article

References (45)

1. Ko, L.J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
2. Hansen, R., and M. Oren. 1997. p53: from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7:46-51.
3. Maltzman, W., and L. Czyzyk. 1981. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell Biol. 4:1689-1694.
4. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
5. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kinichi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 353:345-347.
6. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Prof. Natl. Acad. Sci. USA. 89:7491-7495.
7. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:849-852.
8. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:847-849.
9. Lane, D.P. 1992. Cancer. p53, guardian of the genome. Nature. 358:15-16.
10. Griffiths, S.D., A.R. Clarke, L.E. Healy, G. Ross, A.M. Ford, M.L. Hooper, A.H. Wyllie, and M. Greaves. 1997. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene. 14:523-531.
11. Hayflick, L., and P.S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585-621.
12. Jerkins, J.R., K. Rudge, and G.A. Currie. 1984. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature. 312:651-654.
13. Shay, J.W., O.M. Pereira-Smith, and W.E. Wright. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33-39.
14. Harvey, M., A.T. Sands, R.S. Weiss, M.E. Hegi, R.W. Wiseman, P. Pantazis, B.C. Giovanella, M.A. Tainsky, A. Bradley, and L.A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 8:2457-2467.
15. Moll, U.M., G. Riou, and A.J. Levine. 1992. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA. 89:7262-7266.
16. Moll, U.M., M. LaQuaglia, J. Benard, and G. Riou. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Prof. Natl. Acad. Sci. USA. 92:4407-4411.
17. Maestro, R., A. Gloghini, C. Doglioni, D. Gasparotto, T. Vukosavljevic, V. De Re, L. Laurino, A. Carbone, and M. Boiocchi. 1995. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Blood. 85:3239-3246.
18. Gordon, L.I., and S.A. Weitzman. 1990. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 76:655-663.
19. Christen, S., T.M. Hagen, M.K. Shigenaga, and B.N. Ames. 1999. Chronic infection and inflammation lead to cancer. In Microbes and Malignancy: Infection as a Cause of Cancer. J. Parsonnet and S. Horning, editors. Oxford University Press, Oxford.
20. Weitberg, A.B., S.A. Weitzman, M. Destrempes, S.A. Latt, and T.P. Stossel. 1983. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N. Engl. J. Med. 308:26-30.
21. Weitzman, S.A., A.B. Weitberg, E.P. Clark, and T.P. Stossel. 1985. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science. 227:1231-1233.
22. Gossen, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1766-1769.
23. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:552-557.
24. Morris, P.S., and M. Haas. 1997. A fluorescent p53GFP fusion protein facilitates its detection in mammalian cells while retaining the properties of wild-type p53. Oncogene. 15:2241-2247.
25. Hannon, G.J., P.-Q. Sun, A. Carnero, L. Xie, R. Maestro, D.S. Conklin, and D.H. Beach. 1999. MaRX: an approach to genetics in mammalian cells. Science. 283:1129-1130.
26. Calandra, T., and R. Bucala. 1997. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit. Rev. Immunol. 17:77-88.
27. Maestro, R., A.P. Deitos, Y. Hamamori, S. Krasnokutsky, V. Sartorelli, L. Kedes, C. Doglioni, D. Beach, and G. Hannon. 1999. twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13:2207-2217.
28. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
29. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993, WAF1, a potential mediator of p53 tumor suppression. Cell. 75:817-825.
30. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75: 805-816.
31. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature. 366:701-704.
32. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO (Eur. Mol. Biol. Organ.) J. 13:4816-4822.
33. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO (Eur. Mol. Biol. Organ.) J. 12:461-468.
34. Wu, X., J.H. Bayle, D. Olson, and A.J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
35. El-Deiry, W.S., S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
36. Messmer, U.K., and B. Brune. 1996. Nitric oxide (NO) in apoptotic versus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD + content, and p53 accumulation. Arch. Biochem. Biophys. 327:1-10.
37. Messmer, U.K., and B. Brune. 1996. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 319:299-305.
38. Miyashita, T., and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:293-299.
39. Bacher, M., C.N. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA. 93: 7849-7854.
40. Onodera, S., K. Suzuki, T. Matsuno, K. Kaneda, M. Takagi, and J. Nishihira. 1997. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology. 92:131-137.
41. MacMicking, J., Q.W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
42. Schaffer, C.J., and L.B. Nanney. 1996. Cell biology of wound healing. Int. Rev. Cytol. 169:151-181.
43. Krishna, M., B. Woda, L. Savas, S. Baker, and B. Banner. 1995. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod. Pathol. 8:654-657.
44. Hibi, K., H. Mitomi, W. Koizumi, S. Tanabe, K. Saigenji, and I. Okayasu. 1997. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am. J. Clin. Pathol. 108:26-34.
45. Wotherspoon, A.C. 1998. Helicobafter pylori infection and gastric lymphoma. Br. Med. Bull. 54:79-85.